BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34761616)

  • 1. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
    Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
    J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography.
    Wang D; Huang X; Bai L; Zhang X; Wei J; Zhou J
    Acta Radiol; 2020 Nov; 61(11):1562-1569. PubMed ID: 32088966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of mult-detector CT for papillary renal cell carcinoma and chromophobe renal cell carcinoma].
    Liu X; Zou X; Chen H; Fang X; Hu X; Sun R
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):52-6. PubMed ID: 25877320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
    Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
    Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinoma.
    Kaldany A; Paulucci DJ; Kannappan M; Beksac AT; Anastos H; Okhawere K; Sfakianos JP; Badani KK
    Urol Oncol; 2019 Oct; 37(10):727-734. PubMed ID: 31174958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis.
    Wang W; Cao K; Jin S; Zhu X; Ding J; Peng W
    Eur Radiol; 2020 Oct; 30(10):5738-5747. PubMed ID: 32367419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
    Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
    Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.
    Xue LY; Lu Q; Huang BJ; Li Z; Li CX; Wen JX; Wang WP
    Eur J Radiol; 2015 Oct; 84(10):1849-56. PubMed ID: 26149528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of CT and MRI appearances in mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma.
    Lu D; Yuan W; Zhu Q; Ye J; Zhu W; Chen W
    Br J Radiol; 2021 Oct; 94(1126):20210548. PubMed ID: 34478331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
    Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
    Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.
    Mnatzakanian GN; Shinagare AB; Sahni VA; Hirsch MS; Silverman SG
    Abdom Radiol (NY); 2016 Nov; 41(11):2187-2195. PubMed ID: 27383741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of multiparametric magnetic resonance imaging in the differentiation of clear cell renal cell cancer.
    Aydoğan C; Cansu A; Aydoğan Z; Erdemi S; Teymur A; Bektaş O; Mungan S; Kazaz İO
    Abdom Radiol (NY); 2023 Jul; 48(7):2349-2360. PubMed ID: 37071122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Value of Contrast-Enhanced Ultrasound in Diagnosing Small Renal Cell Carcinoma Subtypes and Angiomyolipoma.
    Cao H; Fang L; Chen L; Zhan J; Diao X; Liu Y; Lu C; Zhang Z; Chen Y
    J Ultrasound Med; 2022 Jun; 41(6):1415-1423. PubMed ID: 34499770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
    Wei S; Tian F; Xia Q; Huang P; Zhang Y; Xia Z; Wu M; Yang B
    Cancer Imaging; 2019 Dec; 20(1):1. PubMed ID: 31892340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differentiation of subtypes of renal cell carcinoma by double-phase helical computed tomography].
    Dai JR; Zhang LY; Zhang J; Chen Y; Zhang HT; Jiang LX; Lin M
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2177-81. PubMed ID: 21029656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cortico-medullary phase contrast-enhanced MDCT and T2-weighted MR imaging in the histological subtype differentiation of renal cell carcinoma: radiology-pathology correlation.
    Halefoglu AM; Ozagari AA
    Pol J Radiol; 2021; 86():e583-e593. PubMed ID: 34876939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT.
    Bata P; Gyebnar J; Tarnoki DL; Tarnoki AD; Kekesi D; Szendroi A; Fejer B; Szasz AM; Nyirady P; Karlinger K; Berczi V
    Diagn Interv Radiol; 2013; 19(5):387-92. PubMed ID: 23864331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.